These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 24561675)

  • 1. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
    Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
    Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
    da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
    Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain.
    Espíndola JW; Cardoso MV; Filho GB; Oliveira E Silva DA; Moreira DR; Bastos TM; Simone CA; Soares MB; Villela FS; Ferreira RS; Castro MC; Pereira VR; Murta SM; Sales Junior PA; Romanha AJ; Leite AC
    Eur J Med Chem; 2015 Aug; 101():818-35. PubMed ID: 26231082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against Trypanosoma cruzi.
    de Oliveira Filho GB; de Oliveira Cardoso MV; Espíndola JW; Ferreira LF; de Simone CA; Ferreira RS; Coelho PL; Meira CS; Magalhaes Moreira DR; Soares MB; Lima Leite AC
    Bioorg Med Chem; 2015 Dec; 23(23):7478-86. PubMed ID: 26549870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity.
    Moreira DR; Leite AC; Cardoso MV; Srivastava RM; Hernandes MZ; Rabello MM; da Cruz LF; Ferreira RS; de Simone CA; Meira CS; Guimaraes ET; da Silva AC; dos Santos TA; Pereira VR; Soares MB
    ChemMedChem; 2014 Jan; 9(1):177-88. PubMed ID: 24203393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents.
    Caputto ME; Fabian LE; Benítez D; Merlino A; Ríos N; Cerecetto H; Moltrasio GY; Moglioni AG; González M; Finkielsztein LM
    Bioorg Med Chem; 2011 Nov; 19(22):6818-26. PubMed ID: 22000947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
    Greenbaum DC; Mackey Z; Hansell E; Doyle P; Gut J; Caffrey CR; Lehrman J; Rosenthal PJ; McKerrow JH; Chibale K
    J Med Chem; 2004 Jun; 47(12):3212-9. PubMed ID: 15163200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of thiosemicarbazones and semicarbazones as potential agents anti-Trypanosoma cruzi.
    Soares RO; Echevarria A; Bellieny MS; Pinho RT; de Leo RM; Seguins WS; Machado GM; Canto-Cavalheiro MM; Leon LL
    Exp Parasitol; 2011 Dec; 129(4):381-7. PubMed ID: 21939658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
    dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF
    Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies toward the structural optimization of novel thiazolylhydrazone-based potent antitrypanosomal agents.
    Hernandes MZ; Rabello MM; Leite AC; Cardoso MV; Moreira DR; Brondani DJ; Simone CA; Reis LC; Souza MA; Pereira VR; Ferreira RS; McKerrow JH
    Bioorg Med Chem; 2010 Nov; 18(22):7826-35. PubMed ID: 20961766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Chlorophenylthioacetone-derived thiosemicarbazones as potent antitrypanosomal drug candidates: Investigations on the mode of action.
    Rodney Rodrigues de Assis D; Almeida Oliveira A; Luiz Porto S; Aparecida Nonato Rabelo R; Burgarelli Lages E; Corrêa Santos V; Marques Milagre M; Perdigão Fragoso S; Martins Teixeira M; Salgado Ferreira R; Renato Machado C; Antônio Miranda Ferreira L; Lucio Speziali N; Beraldo H; Simão Machado F
    Bioorg Chem; 2021 Aug; 113():105018. PubMed ID: 34098396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antiparasitic activity of new thiosemicarbazones in strains of Trypanosoma cruzi.
    Moreno-Rodríguez A; Salazar-Schettino PM; Bautista JL; Hernández-Luis F; Torrens H; Guevara-Gómez Y; Pina-Canseco S; Torres MB; Cabrera-Bravo M; Martinez CM; Pérez-Campos E
    Eur J Med Chem; 2014 Nov; 87():23-9. PubMed ID: 25238291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-(phenylthio)ethylidene derivatives as anti-Trypanosoma cruzi compounds: Structural design, synthesis and antiparasitic activity.
    Cardoso MVO; Oliveira Filho GB; Siqueira LRP; Espíndola JWP; Silva EBD; Mendes APO; Pereira VRA; Castro MCAB; Ferreira RS; Villela FS; Costa FMRD; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2019 Oct; 180():191-203. PubMed ID: 31306906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural investigation of anti-Trypanosoma cruzi 2-iminothiazolidin-4-ones allows the identification of agents with efficacy in infected mice.
    Moreira DR; Costa SP; Hernandes MZ; Rabello MM; de Oliveira Filho GB; de Melo CM; da Rocha LF; de Simone CA; Ferreira RS; Fradico JR; Meira CS; Guimarães ET; Srivastava RM; Pereira VR; Soares MB; Leite AC
    J Med Chem; 2012 Dec; 55(24):10918-36. PubMed ID: 23167554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum-based complexes of bioactive 3-(5-nitrofuryl)acroleine thiosemicarbazones showing anti-Trypanosoma cruzi activity.
    Vieites M; Otero L; Santos D; Olea-Azar C; Norambuena E; Aguirre G; Cerecetto H; González M; Kemmerling U; Morello A; Diego Maya J; Gambino D
    J Inorg Biochem; 2009 Mar; 103(3):411-8. PubMed ID: 19187969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
    Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
    Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity on Trypanosoma cruzi, erythrocytes lysis and biologically relevant physicochemical properties of Pd(II) and Pt(II) complexes of thiosemicarbazones derived from 1-indanones.
    Santos D; Parajón-Costa B; Rossi M; Caruso F; Benítez D; Varela J; Cerecetto H; González M; Gómez N; Caputto ME; Moglioni AG; Moltrasio GY; Finkielsztein LM; Gambino D
    J Inorg Biochem; 2012 Dec; 117():270-6. PubMed ID: 23063173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain.
    Du X; Guo C; Hansell E; Doyle PS; Caffrey CR; Holler TP; McKerrow JH; Cohen FE
    J Med Chem; 2002 Jun; 45(13):2695-707. PubMed ID: 12061873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of new aryl thiosemicarbazone as antichagasic candidates.
    Blau L; Menegon RF; Trossini GH; Molino JV; Vital DG; Cicarelli RM; Passerini GD; Bosquesi PL; Chin CM
    Eur J Med Chem; 2013 Sep; 67():142-51. PubMed ID: 23851115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.